NCBiotech News

It was a fortuitous connection when Jay Annis, an entrepreneurial nurse anesthetist from Farmville, was able to team with Farmville’s newly expanding medical device manufacturer D R Burton to build a better intubation device.

Durham-based MED-EL USA is giving away merchandise through a Facebook campaign leading up to Mother's Day, to help raise awareness of the importance of hearing and interventions that can help restore access to the world of sound.

The co-chairs, event team and awards committee have been selected for Triad BioNight, a June 20 event in Greensboro that will celebrate bioscience growth and honor industry leaders in North Carolina’s Piedmont Triad region.

Local scientists tell attendees at the North Carolina Biotechnology Center’s May Ag Tech Professional Forum how increasing nighttime temperatures have a dramatic, negative effect on plants.

HemoSonics -- a Charlottesville, VA-based business with R&D and manufacturing operations in Durham -- is about to expand after receiving FDA marketing authorization for its Quantra Hemostasis platform for use during cardiac and major orthopedic surgeries.

The National Cancer Institute and Eva Garland Consulting have teamed up to help small businesses apply for Phase I of the federally funded SBIR and STTR grant programs.

The newly published "2018: Evidence and Opportunity: Impact of Life Sciences in North Carolina," is a fascinating statistical tale of the state's transformation, and the Biotechnology Center's 35-year contribution to it.

Precise Bio, a Winston-Salem regenerative medicine startup, has developed a laser-based biological “printer” that can fabricate tissues and organs from living cells in three dimensions, just as they are structured in the body.

Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, has received U.S. Food and Drug Administration approval of Duaklir Pressair, a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD).

Three North Carolina life science innovators strongly recommend others follow their lead and seek out the many resources provided by NCBiotech.

The Research Triangle region hosts a growing ag tech industry as it combines history and innovation, draws on both urban and rural resources, and thrives on partnerships among private companies, government and academic institutions.

Durham-based Hatteras Venture Partners has completed a first closing of $94 million on a new investment fund that it hopes will reach $200 million.

Asklepios BioPharmaceutical, (AskBio), a Research Triangle Park platform company playing a key role in North Carolina’s global gene therapy leadership, got a $235 million vote of confidence today.

Durham-based Mycovia Pharmaceuticals, a developer of drugs in women’s health, has shown that its oral drug candidate VT-1598 is active against Candida auris, an emerging multi-drug resistant fungal pathogen that presents a serious global health threat.

Triad BioNight 2019, an event showcasing bioscience growth and honoring industry leaders in the Piedmont Triad region, is scheduled for June 20 at the Grandover Resort and Conference Center in Greensboro.